New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change.

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

An allergic reaction happens when your body attacks a foreign, and typically harmless, substance. Here’s how to tell if ...

The third week of September is known as "peak week" by many asthma and allergy associations because emergency room visits and ...

Breastfeeding through the first year of infants' lives can lower their risk of asthma by colonizing their bodies wi ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

EGPA, previously known as Churg-Strauss syndrome, is a rare inflammatory disorder characterized by asthma, necrotizing ...

The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...

Short-term ICS use in asthma, at moderate to high doses daily, may lead to significant but uncommon risk for adverse CV and pulmonary outcomes.

Dr. Scott Cyrus offers expert insights into asthma, including common symptoms, effective treatments, and management strategies to improve the quality of life for those affected by the condition.

Gappa's advice for advocacy includes understanding the burden of respiratory disease among children in your area and knowing the factors that affect childhood respiratory health. Use state-of-the-art ...